Company / Operating Cash Flow per Share
DNA X, Inc. Operating Cash Flow per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.92
FY2024
5-year range
-$2.05 / -$0.30
FY2020-FY2024
Trend
-202.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -202% YoY in FY2024, a notable deviation from the 5-year average annual change of -181%.
Based on SEC 10-K filings.
-0.92 in FY2024.
Improved from $-2.05 to $-0.92 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating cash flow per share decreased 202.0% year-over-year.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.92 | -202.0% |
| FY2023 | -$0.30 | +85.2% |
| FY2022 | -$2.05 | -28.5% |
| FY2021 | -$1.59 | +2.9% |
| FY2020 | -$1.64 | -762.4% |
| FY2019 | $0.25 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026